During the past decade, Bruyère Research Institute conducted 15 clinical trials. In the 10-year time frame, 15 clinical trials started and 1 clinical trials were completed, i.e. on average, 6.7% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 1 clinical trials were completed. i.e. 25% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Bruyère Research Institute" #1 sponsor was "Bruyere Research Institute" with 5 trials, followed by "Eli Lilly and Company" with 3 trials sponsored, "Ottawa Hospital Research Institute" with 3 trials sponsored, "Société des Produits Nestlé (SPN)" with 2 trials sponsored and "Alector Inc." with 2 trials sponsored. Other sponsors include 0 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Bruyère Research Institute" #1 collaborator was "Bruyere Research Institute" with 3 trials as a collaborator, "Canadian Institutes of Health Research (CIHR)" with 3 trials as a collaborator, "Canadian Center for Vaccinology" with 2 trials as a collaborator, "AbbVie" with 1 trials as a collaborator and "Alberta Prion Research Institute" with 1 trials as a collaborator. Other collaborators include 24 different institutions and companies that were collaborators in the rest 34 trials.

According to Clinical.Site data, the most researched conditions in "Bruyère Research Institute" are "Alzheimer Disease" (7 trials), "Dementia" (3 trials), "Influenza" (2 trials), "Mild Cognitive Impairment" (2 trials) and "Aging" (1 trials). Many other conditions were trialed in "Bruyère Research Institute" in a lesser frequency.

Most popular intervention types in "Bruyère Research Institute" are "Device" (6 trials), "Behavioral" (5 trials), "Drug" (5 trials), "Other" (4 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "AL002" (1 trials), "Active Neuro RX Gamma device" (1 trials), "Computerized cognitive battery: Cognigram (CG)" (1 trials) and "Control Group" (1 trials). Other intervention names were less common.

The vast majority of trials in "Bruyère Research Institute" are 18 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Bruyère Research Institute". undefined are not yet recruiting, 5 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 9 completed trials in Bruyère Research Institute, 1 suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Bruyère Research Institute, 0 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 9 trials that are defined as “Not Applicable".